Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ablation clinical trials
4 of 5 indexed Ablation trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Ablation: 5 US clinical trials tracked, 4 recruiting.
Ablation is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Pulse Biosciences, running 2 of these trials.
Enrollment posture brief
Registry condition ablation
OPEN 4 | RECR 80% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)
Ablation lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ablation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ablation is recruiting above its size-band peers.
4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ablation research.
Pulse Biosciences accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Ablation enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Ablation research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
Pulse Biosciences
NCT06959121
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
Pulse Biosciences
NCT07287176
Torque Device Evaluation
University of Minnesota
NCT07094256
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
Urological Research Network
NCT05698576
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Abbott Medical Devices
NCT06172699
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Ablation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ablation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ablation page
5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Ablation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pulse Biosciences sponsors the most Ablation trials on record, review their full trial history before evaluating a specific study. See Pulse Biosciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ablation condition card totals 5 registered trials; most-linked intervention Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.